GUBRA A/S revenue for the last year amounted to 205.00 M DKK, the most of which — 168.56 M DKK — came from its highest performing source at the moment, Pre-Clinical Contract Research, the year earlier bringing 130.62 M DKK. The greatest contribution to the revenue figure was made by United States — last year it brought GUBRA A/S 86.00 M DKK, and the year before that — 67.00 M DKK.